Differentiation and hematopoietic-support of clonal cells in myelodysplastic syndromes

Leukemia and Lymphoma

Volumn 48, Issue 7, 2007, Pages 1353-1371

  Li, Xiao ^a   Wu, LingYun ^a   Ying, Shaoxu ^a   Chang, Chunkang ^a   He, Qi ^a   Pu, Quan ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Clone; Differentiation; Hematopoiesis; Myelodysplastic syndromes

Indexed keywords

DIHYDRORHODAMINE 123;

ADULT; AGED; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CLONAL VARIATION; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GRANULOCYTE; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MEGAKARYOCYTE; MYELODYSPLASTIC SYNDROME; NEUTROPHIL; PRIORITY JOURNAL;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; BLAST CRISIS; BLOOD CELLS; BONE MARROW CELLS; CELL DIFFERENTIATION; CLONE CELLS; FEMALE; HEMATOPOIESIS; HUMANS; KARYOTYPING; LEUKEMIA, MYELOID; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; NEUTROPHILS;

EID: 34447545675     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190701395065     Document Type: Article

References (29)

1. Valent, P., Wimazal, F., Schwarzinger, I., Sperr, W. R. and Geissler, K. (2003) Pathogenesis, classification, and treatment of myelodysplastic syndromes (MDS). Wien Klin Wochenschr, 115, pp. 515-536.
2. Marisavljevic, D., Rolovic, Z., Ludoski-Pantic, M., Djordjevic, V. and Novak, A. (2005) Spontaneous remission in adults with primary myelodysplastic syndromes: Incidence and characteristics of patients. Med Oncol, 22, pp. 407-410.
3. Maywald, O., Buchheidt, D., Bergmann, J., Schoch, C., Ludwig, W. D. and Reiter, A. (2004) Spontaneous remission in adult acute myeloid leukemia in association with systemic bacterial infection-case report and review of the literature. Ann Hematol, 83, pp. 189-194.
4. Bernell, P., Jacobsson, B., Nordgren, A. and Hast, R. (1996) Clonal cell lineage involvement in myelodysplastic syndromes studied by fluorescence in situ hybridization and morphology. Leukemia, 10, pp. 662-668.
5. Krejcova, H., Neuwirtova, R., Cermak, J., Belickova, M. and Brdicka, R. (2002) Cell clonality in myelodysplastic syndrome. Sb Lek, 103, pp. 339-348.
6. Koeffler, H. P. and Golde, D. W. (1980) Human preleukemia. Ann Int Med, 93, pp. 347-353.
7. Saitoh, K., Miura, I., Takahashi, N. and Miura, A. B. (1998) Fluorescence in situ hybridization of progenitor cells obtained by fluorescence-activated cell sorting for the detection of cells affected by chromosome abnormality trisomy 8 in patients with myelodysplastic syndromes. Blood, 92, pp. 2886-2892.
8. Cauwelier, B., Nollet, F., De Laere, E., Van Leeuwen, M., Billiet, J., Criel, A. and Louwagie, A. (2002) Simultaneous occurrence of myelodysplastic syndrome and monoclonal B lymphocytes with a different clonal origin. Leuk Lymphoma, 43, pp. 191-193.
9. Delacretaz, F., Schmidt, P. M., Piguet, D., Bachmann, F. and Costa, J. (1987) Histopathology of myelodysplastic syndromes. The FAB classification (proposals) applied to bone marrow biopsy. Am J Clin Pathol, 87, pp. 180-186.
10. Multani, A. S., Hopwood, V. L. and Pathak, S. (1996) A modified fluorescence in situ hybridization (FISH) technique. Anticancer Res, 16, pp. 3435-3437.
11. van Lom, K., Houtsmuller, A. B., van Putten, W. L., Slater, R. M. and Lowenberg, B. (1999) Cytogenetic clonality analysis of megakaryocytes in myelodysplastic syndrome by dual-color fluorescence in situ hybridization and confocal laser scanning microscopy. Genes Chromosomes Cancer, 25, pp. 332-338.
12. Alvarez-Larran, A., Toll, T., Rives, S. and Estella, J. (2005) Assessment of neutrophil activation in whole blood by flow cytometry. Clin Lab Haematol, 27, pp. 41-46.
13. Levine, R. F. (1980) Isolation and characterization of normal human megakaryocytes. Br J Haematol, 45, pp. 487-497.
14. Beris, P. (1989) Primary clonal myelodysplastic syndromes. Sem Hematol, 26, pp. 216-233.
15. Thanopoulou, E., Cashman, J., Kakagianne, T., Eaves, A., Zoumbos, N. and Eaves, C. (2004) Engraftment of NOD/SCID-beta2 microglobulin null mice with multilineage neoplastic cells from patients with myelodysplastic syndrome. Blood, 103, pp. 4285-4293.
16. Galton, D AG (1986) The myelodysplastic syndrome. Scan Ematol, 36, p. 11.
17. Schmetzer, H. M., Poleck, B., Duell, T., Gerhartz, H. H. and Mittermuller, J. (2000) Cytogenetic and Southern blot analysis to demonstrate clonality and to estimate prognosis in patients with myelodysplastic syndromes. Ann Hematol, 79, pp. 20-29.
18. Greenberg, P., Cox, C., LeBeau, M. M., Fenaux, P., Morel, P. and Sanz, G. (1997) International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood, 89, pp. 2079-2088.
19. Ohyashiki, K., Sasao, I., Ohyashiki, J. H., Murakami, T., Tauchi, T., Iwabuchi, A. and Toyama, K. (1992) Cytogenetic and clinical findings of myelodysplastic syndromes with a poor prognosis. An experience with 97 cases. Cancer, 70, pp. 94-99.
20. Ishikawa, S., Sasaki, Y., Hirota, M., Okumura, N., Furihata, K. and Tozuka, M. (1997) Determination of neutrophil function by measuring superoxide production with whole blood flow cytometry. Rinsho Byori, 45, pp. 1057-1061.
21. Verhoef, G. and Boogaerts, M. (1991) In vivo administration of granulocyte-macrophage colony stimulating factor enhances neutrophil function in patients with myelodysplastic syndromes. Br J Haematol, 79, pp. 177-184.
22. Rajnoldi, A Cantu, Fenu, S., Kerndrup, G., van Wering, E. R., Niemeyer, C. M. and Baumann, I. (2005) European Working Group on Myelodysplastic Syndromes in Childhood (EWOG-MDS). Evaluation of dysplastic features in myelodysplastic syndromes: Experience from the morphology group of the European Working Group of MDS in Childhood (EWOG-MDS). Ann Hematol, 84, pp. 429-433.
23. Hast, R., Eriksson, M., Widell, S., Arvidsson, I. and Bemell, P. (1999) Neutrophil dysplasia is not a specific feature of the abnormal chromosomal clone in myelodysplastic syndromes. Leuk Res, 23, pp. 579-584.
24. (2005) Megakaryocytopoiesis and apoptosis in patients with myelodysplastic syndromes. Leuk Lymphoma, 46, pp. 387-391.
25. Bryant, C. E. and Deeg, H. J. (2004) Simultaneous demonstration of clonal chromosome abnormalities and apoptosis in individual marrow cells in myelodysplastic syndrome. Int J Hematol, 80, pp. 140-145.
26. Nilsson, L., Astrand-Grundstrom, I., Anderson, K., Arvidsson, I., Hokland, P. and Bryder, D. (2002) Involvement and functional impairment of the CD34(+)CD38(-)Thy-1(+) hematopoietic stem cell pool in myelodysplastic syndromes with trisomy 8. Blood, 100, pp. 259-267.
27. White, A. D., Hoy, T. G. and Jacobs, A. (1994) Extended cytogenetic follow-up and clinical progress in patients with myelodysplastic syndromes (MDS). Leuk Lymphoma, 12, pp. 401-412.
28. Swolin, B., Rodjer, S. and Roupe, G. (2000) Cytogenetic studies in patients with mastocytosis. Cancer Genet Cytogenet, 20, pp. 31-135.
29. Sloand, E. M., Mainwaring, L., Fuhrer, M., Ramkissoon, S., Risitano, A. M. and Keyvanafar, K. (2005) Preferential suppression of trisomy 8 compared with normal hematopoietic cell growth by autologous lymphocytes in patients with trisomy 8 myelodysplastic syndrome. Blood, 106, pp. 841-851.